109541 ⎘
Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from cancer cells, e.g. reversion of tumour cells
PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING MALIGNANT BREAST CANCER
#2MODIFIED IMMUNE CELLS FOR TREATING AND/OR PREVENTING METASTASIS
#3PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY
#4PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY
#5PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY
#6METHODS FOR EXPANDING HEMATOPOIETIC STEM CELLS USING REVITALIZED MESENCHYMAL STEM CELLS
#7METHOD FOR PRODUCING IMMUNE CELL COMPOSITION
#8METHOD FOR DIAGNOSIS AND/OR PROGNOSIS OF LIVER DISEASE PROGRESSION AND RISK OF HEPATOCELLULAR CARCINOMA AND DISCOVERY OF THERAPEUTIC COMPOUNDS AND TARGETS TO TREAT LIVER DISEASE AND CANCER
#9COMPOSITION AND METHODS FOR PRODUCING ADULT LIVER ORGANOIDS
#10METHOD FOR PREPARING FIBROSIS-ENCAPSULATED TUMOROID, AND USE THEREOF
#11PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY
#12PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY
#13Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#14PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY
#15Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#16PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY
#17Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#18PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY
#19Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#20Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#21Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#22PANCREATIC ENDOCRINE CELLS, METHOD FOR PRODUCING SAME, AND TRANSDIFFERENTIATION AGENT
#23Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#24Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#25Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#26Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#27Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#28Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#29Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#30Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#31Clinical Gene Signature-Based Human Cell Culture Model and Uses Thereof
#32Delta133P53Beta and Delta133P53Gamma isoforms are biomarkers of cancer stem cells
#33Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#34PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY
#35PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY
#36ASSEMBLOID - 3D MIMETIC TISSUE STRUCTURE BASED ON PATIENT- DERIVED MULTIPLE CELL TYPES AND METHOD OF MANUFACTURING THE SAME
#37Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#38METHODS UTILIZING SINGLE CELL GENETIC DATA FOR CELL POPULATION ANALYSIS AND APPLICATIONS THEREOF
#39REPROGRAMMING OF A DIFFERENTIATED CELL TO AN UNDIFFERENTIATED CELL USING EXOSOME
#40TEMOZOLOMIDE RESISTANT CELLS AND AN INTEGRATED METHOD FOR CHARACTERIZING THE SAME
#41Methods for expanding hematopoietic stem cells using revitalized mesenchymal stem cells
#42Pancreatic endocrine cells, method for producing same, and transdifferentiation agent
#43Cellular test systems for the determination of the biological activities of neurotoxin polypeptides
#44Methods, systems and compositions relating to cell conversion via protein-induced in-vivo cell reprogramming
#45Composition for inducing dedifferentiation into cancer stem cells comprising ribosome-activating inhibitor as active ingredient, cancer organoid culture method and anticancer drug screening platform based thereon
#46METHODS OF CONTROLLING CELL FATE AND CONSEQUENCES FOR DISEASE
#47Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#48Clinical gene signature-based human cell culture model and uses thereof
#49Method for inducing cell reprogramming, and method for producing pluripotent cells
#50Delta133p53beta and delta133p53gamma isoforms are biomarkers of cancer stem cells
#51Pancreatic endocrine cells, method for producing same, and transdifferentiation agent
#52A METHOD TO UP-REGULATE CANCER STEM CELL MARKERS FOR THE GENERATION OF ANTIGEN SPECIFIC CYTOTOXIC EFFECTOR T CELLS
#53Methods of controlling cell fate and consequences for disease
#54TUMOR STEM CELLS
#55METHOD FOR CULTURE OF HUMAN BLADDER CELL LINES AND ORGANOIDS AND USES THEREOF
#56Administration of Angiocidin for the Treatment of Cancer
#57Small molecule transcription modulators of bromodomains
#58Methods and compositions for targeting cancer stem cells
#59COMPOSITIONS AND METHODS FOR INDUCING DIFFERENTIATION OF STEM CELLS
#60Generation of patient-specific differentiated cell types by epigenetic induction
#61Methods, systems and compositions relating to cell conversion via protein-induced in-vivo cell reprogramming
#62Cellular test systems for the determination of the biological activities of neurotoxin polypeptides
#63COMPOUNDS AND METHODS FOR SELECTIVELY TARGETING CANCER STEM CELLS
#64Generation of patient-specific differentiated cell types by epigenetic induction
#65Methods for producing cells having a phenotype of a primary human hepatocytes and compositions
#66Epigenetic induction of human patient-specific self-propagating dopaminergic neuron cell
#67Triazine derivatives as differentiation catalysts
#68Thermoplastic resin composition for impact absorbing member and method for producing same
#69Production method for artificial cancer stem cell and induced differentiation method therefor
#70Generation of patient-specific differentiated cell types by epigenetic induction
#71TUMOR STEM CELLS
#72Administration of angiocidin for the treatment of leukemia
#73Generation of patient-specific differentiated cell types by epigenetic induction
#74SUBSTRATE AND METHOD FOR CULTURING BREAST CELLS
#75Immortal Pluripotent Stem Cell Line, Cell Lines Derived Therefrom, Methods of Preparing Thereof and Their Uses
#76Method for Inducing the Differentiation of Human Myelogenous Leukemia Cells Into Megakarocytes or Thrombocytes
#77Method for production of neurons from cells of a cell line
#78Reversibly immortalised olfactory ensheathing glia and their use to promote neuronal regeneration
#79Host cells obtained by introducing and expressing VHL gene in cancer cells or embryonic stem cells
#80Method for producing a population of homozygous stem cells having a pre-selected immunotype and/or genotype, cells suitable for transplant derived therefrom, and materials and methods using same
#81Vaccine composition comprising Flt3-ligand
#82Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy